MANAGEMENT TEAM

Alain Jordan, MSc (Chief Operating Officer)

André Mercanzini, PhD (Chief Technology Officer)

Alain Dransart, MSc (Clinical and Regulatory Affairs Director)


INDUSTRY

Medical Device, Neurostimulation, Deep Brain Stimulation (DBS)


FOUNDED

August 2008


TECHNOLOGY

microDBS Technology: MEMS technology applied to neuromodulation lead’s electrode


PRODUCTS

directSTIM DBS System: DBS System allowing directional stimulation for treatment of movement disorders

spiderSTIM: Retractable intra-operative electrode for DBS surgery


CURRENT INVESTORS

Private investors

BiomedInvest II

BB Biotech Ventures III

Initiative Capital Romandie

BV5 FPCI

Greatbatch


FUNDING TO DATE

42 MUSD


BOARD OF DIRECTORS

Oern Stuge, MD, MBA (Executive Chairman)

Markus Hosang, PhD

Juerg Eckhardt, MD

Martin Velasco

Philippe Dro, PhD, MBA

Anthony W. Borowicz, MBA


ADVISORY BOARD

Andres Lozano, MD, PhD

Philippe Renaud, PhD


NUMBER OF EMPLOYEES

Fifteen employees



_________________________




ALEVA NEUROTHERAPEUTICS SA

EPFL Innovation Park, Building D

CH 1015 Lausanne, Switzerland

Email: info@aleva-neuro.com

Web: www.aleva-neuro.com

IN SHORT